☀️ Good morning.
I've spent more time than many will believe [making microscopic observations], but I've done them with joy, and I've taken no notice those who have said why take so much trouble and what good is it? - Antonie van Leeuwenhoek
📰 Bioengineering in the News
Now 100% more streamlined.
BIASED GENETIC GENEALOGIES: An investigation by The Atlantic found that, out of more than 100 homicide cases solved using genetic genealogy—which helped identify the Golden State Killer—only four involved a Black victim. The Atlantic. Link
THE FUTURE IS BACON: A last-minute deal by the Trump administration may speed up the approval of gene-edited animals. Future Human. Link
TALEN vs. CRISPR: TALENs are up to five times better than CRISPR-Cas9 when it comes to editing DNA inside of densely-packed heterochromatin, according to a study from researchers at the University of Illinois. Press Release. Link
CHEAPER GENE THERAPIES: Cell and gene therapies are currently expensive, but new technology could bring down costs. Labiotech.eu. Link
SINGLE CELLS: Take an in-depth look at single-cell sequencing technologies in this explainer article. Labiotech.eu. Link
Synthetic biology companies raised about $7.8 billion in 2020, according to a market report. SynBioBeta. Link
Solugen, a Houston, Tx. based developer of biomanufactured chemicals, skipped out on a round of funding, last year, that would have valued the company at more than $1 billion. That’s according to a report from Tech Crunch. Link
Thanks for reading Cell Crunch, part of Bioeconomy.XYZ. If you enjoy this newsletter, please share it with a friend or colleague. A version of these newsletters is also posted on Medium. Reach me with tips and feedback on Twitter @NikoMcCarty or via email.